Boston Scientific Securities Fraud Class Action
Boston Scientific · Boston Scientific securities · Ongoing Litigation
About this case
The complaint alleges that Boston Scientific and certain defendants made materially misleading statements about the sustainability of growth in the company's U.S. electrophysiology segment, competitive pressures, market share, and financial guidance between July 23, 2025 and February 3, 2026. The securities fraud class action is described as ongoing, and the article announces a lead-plaintiff deadline of May 4, 2026.
Case overview
- Defendant company
- Boston Scientific
- Product or service
- Boston Scientific securities
- Court case number
- 26-cv-40075
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Lead plaintiff application
Participation information
Availability is based on each listed participation option and its deadline.
Lead plaintiff application
Investors who suffered losses in Boston Scientific securities were invited to seek appointment as lead plaintiff.
Contact the Law Offices of Howard G. Smith to discuss participation or learn more about the lead-plaintiff process.
- Type
- Lead Plaintiff
- Status
- Deadline passed
Absent class member status
The article states that class members need not take action at this time and may remain absent members of the class action.
No action is required at this time according to the article; class members may retain counsel of their choice or take no action.
- Type
- Other
- Status
- No action required
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- Boston Scientific Securities Fraud Class Action
Barchart.com ·